Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Nov, 2016 | Pages:
722 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology) pipeline landscape. Head and Neck Cancer Squamous Cell Carcinoma is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx. The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Head And Neck Cancer Squamous Cell Carcinoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Head And Neck Cancer Squamous Cell Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 14, 49, 49, 2, 23, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 2, 4 and 2 molecules, respectively.Head And Neck Cancer Squamous Cell Carcinoma. Head And Neck Cancer Squamous Cell Carcinoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer Squamous Cell Carcinoma (Oncology). - The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer Squamous Cell Carcinoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Head And Neck Cancer Squamous Cell Carcinoma (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Head And Neck Cancer Squamous Cell Carcinoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer Squamous Cell Carcinoma (Oncology) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer Squamous Cell Carcinoma (Oncology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer Squamous Cell Carcinoma (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents Table of Contents 2 Introduction 6 Head And Neck Cancer Squamous Cell Carcinoma Overview 7 Therapeutics Development 8 Head And Neck Cancer Squamous Cell Carcinoma - Therapeutics under Development by Companies 10 Head And Neck Cancer Squamous Cell Carcinoma - Therapeutics under Investigation by Universities/Institutes 17 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Products Glance 18 Head And Neck Cancer Squamous Cell Carcinoma - Products under Development by Companies 22 Head And Neck Cancer Squamous Cell Carcinoma - Products under Investigation by Universities/Institutes 32 Head And Neck Cancer Squamous Cell Carcinoma - Companies Involved in Therapeutics Development 33 Head And Neck Cancer Squamous Cell Carcinoma - Therapeutics Assessment 118 Drug Profiles 148 Head And Neck Cancer Squamous Cell Carcinoma - Dormant Projects 682 Head And Neck Cancer Squamous Cell Carcinoma - Discontinued Products 687 Head And Neck Cancer Squamous Cell Carcinoma - Product Development Milestones 689 Appendix 704
List of Tables Number of Products under Development for Head And Neck Cancer Squamous Cell Carcinoma, H2 2016 25 Number of Products under Development for Head And Neck Cancer Squamous Cell Carcinoma - Comparative Analysis, H2 2016 26 Number of Products under Development by Companies, H2 2016 27 Number of Products under Development by Companies, H2 2016 (Contd..1) 28 Number of Products under Development by Companies, H2 2016 (Contd..2) 29 Number of Products under Development by Companies, H2 2016 (Contd..3) 30 Number of Products under Development by Companies, H2 2016 (Contd..4) 31 Number of Products under Development by Companies, H2 2016 (Contd..5) 32 Number of Products under Development by Companies, H2 2016 (Contd..6) 33 Number of Products under Investigation by Universities/Institutes, H2 2016 34 Comparative Analysis by Late Stage Development, H2 2016 35 Comparative Analysis by Clinical Stage Development, H2 2016 36 Comparative Analysis by Early Stage Development, H2 2016 37 Comparative Analysis by Unknown Stage Development, H2 2016 38 Products under Development by Companies, H2 2016 39 Products under Development by Companies, H2 2016 (Contd..1) 40 Products under Development by Companies, H2 2016 (Contd..2) 41 Products under Development by Companies, H2 2016 (Contd..3) 42 Products under Development by Companies, H2 2016 (Contd..4) 43 Products under Development by Companies, H2 2016 (Contd..5) 44 Products under Development by Companies, H2 2016 (Contd..6) 45 Products under Development by Companies, H2 2016 (Contd..7) 46 Products under Development by Companies, H2 2016 (Contd..8) 47 Products under Development by Companies, H2 2016 (Contd..9) 48 Products under Investigation by Universities/Institutes, H2 2016 49 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by AB Science SA, H2 2016 50 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by AbbVie Inc, H2 2016 51 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Accelerated Pharma, Inc., H2 2016 52 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Acceleron Pharma, Inc., H2 2016 53 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Adaptimmune Therapeutics Plc, H2 2016 54 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Advaxis, Inc., H2 2016 55 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Altor BioScience Corporation, H2 2016 56 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Amgen Inc., H2 2016 57 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by AstraZeneca Plc, H2 2016 58 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by AVEO Pharmaceuticals, Inc., H2 2016 59 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Bayer AG, H2 2016 60 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Bionovis SA, H2 2016 61 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by BioNTech AG, H2 2016 62 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Boehringer Ingelheim GmbH, H2 2016 63 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Bristol-Myers Squibb Company, H2 2016 64 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Calithera Biosciences, Inc., H2 2016 65 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by CEL-SCI Corporation, H2 2016 66 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Cellceutix Corporation, H2 2016 67 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Celldex Therapeutics, Inc., H2 2016 68 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Centrose LLC, H2 2016 69 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Critical Outcome Technologies Inc., H2 2016 70 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by CytImmune Sciences, Inc., H2 2016 71 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Daiichi Sankyo Company, Limited, H2 2016 72 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Eisai Co., Ltd., H2 2016 73 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Eleven Biotherapeutics Inc., H2 2016 74 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Eli Lilly and Company, H2 2016 75 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Etubics Corporation, H2 2016 76 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 77 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2016 78 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by GeneSegues Inc, H2 2016 79 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Genexine, Inc., H2 2016 80 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Genmab A/S, H2 2016 81 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by GlaxoSmithKline Plc, H2 2016 82 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Gliknik, Inc., H2 2016 83 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Glycotope GmbH, H2 2016 84 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016 85 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Horizon Pharma Plc, H2 2016 86 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Immunomedics, Inc., H2 2016 87 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Immunovative Therapies, Ltd., H2 2016 88 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Incyte Corporation, H2 2016 89 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 90 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Innate Pharma S.A., H2 2016 91 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Inovio Pharmaceuticals, Inc., H2 2016 92 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by IRX Therapeutics, Inc., H2 2016 93 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Johnson & Johnson, H2 2016 94 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016 95 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Laboratoires Pierre Fabre SA, H2 2016 96 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Loxo Oncology, Inc., H2 2016 97 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Mabion SA, H2 2016 98 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by MacroGenics, Inc., H2 2016 99 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Marsala Biotech Inc., H2 2016 100 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Mateon Therapeutics Inc, H2 2016 101 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by MedImmune LLC, H2 2016 102 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Merck & Co., Inc., H2 2016 103 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Merck KGaA, H2 2016 104 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2016 105 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Millennium Pharmaceuticals Inc, H2 2016 106 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Mirati Therapeutics Inc., H2 2016 107 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Molecular Partners AG, H2 2016 108 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Molplex Ltd., H2 2016 109 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by NanoCarrier Co., Ltd., H2 2016 110 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Novartis AG, H2 2016 111 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Oncobiologics, Inc., H2 2016 112 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Oncolytics Biotech Inc., H2 2016 113 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Onconova Therapeutics, Inc., H2 2016 114 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by OncoSec Medical Incorporated, H2 2016 115 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016 116 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Panacea Biotec Limited, H2 2016 117 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by PCI Biotech Holding ASA, H2 2016 118 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Pfizer Inc., H2 2016 119 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016 120 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Sanofi, H2 2016 121 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2016 122 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Shionogi & Co., Ltd., H2 2016 123 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Sillajen Biotherapeutics, H2 2016 124 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Symphogen A/S, H2 2016 125 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by SynCore Biotechnology Co., Ltd., H2 2016 126 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Takara Bio Inc., H2 2016 127 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Tara Immuno-Oncology Therapeutics LLC, H2 2016 128 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Transgene SA, H2 2016 129 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by UbiVac, LLC, H2 2016 130 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by VasGene Therapeutics, Inc., H2 2016 131 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by VentiRx Pharmaceuticals, Inc., H2 2016 132 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Virttu Biologics Limited, H2 2016 133 Head And Neck Cancer Squamous Cell Carcinoma - Pipeline by Vyriad Inc, H2 2016 134 Assessment by Monotherapy Products, H2 2016 135 Assessment by Combination Products, H2 2016 136 Number of Products by Stage and Target, H2 2016 138 Number of Products by Stage and Mechanism of Action, H2 2016 150 Number of Products by Stage and Route of Administration, H2 2016 162 Number of Products by Stage and Molecule Type, H2 2016 164 Head And Neck Cancer Squamous Cell Carcinoma - Dormant Projects, H2 2016 699 Head And Neck Cancer Squamous Cell Carcinoma - Dormant Projects (Contd..1), H2 2016 700 Head And Neck Cancer Squamous Cell Carcinoma - Dormant Projects (Contd..2), H2 2016 701 Head And Neck Cancer Squamous Cell Carcinoma - Dormant Projects (Contd..3), H2 2016 702 Head And Neck Cancer Squamous Cell Carcinoma - Dormant Projects (Contd..4), H2 2016 703 Head And Neck Cancer Squamous Cell Carcinoma - Discontinued Products, H2 2016 704 Head And Neck Cancer Squamous Cell Carcinoma - Discontinued Products (Contd..1), H2 2016 705
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
